why choose us

First received: May 31, 2023

Clinical Trial: A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Episodic Migraine

Study Type: INTERVENTIONAL


Official Title: Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Pr

Brief Summary: The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.

Read more